Contents Menu

Efficacy of novel transcatheter arterial therapy for hepatocellular carcinoma

山口医学 Volume 60 Issue 5 Page 173-178
published_at 2011-10-31
B030060000503.pdf
[fulltext] 888 KB
Title
肝細胞癌に対する新たな肝動脈カテーテル療法の有用性 (ミニ・レビュー : 中村賞受賞者)
Efficacy of novel transcatheter arterial therapy for hepatocellular carcinoma
Creators Yamasaki Takahiro
Source Identifiers
Creator Keywords
肝細胞癌 肝動脈カテーテル療法 塞栓療法 リピオドール 微小デンプン球
肝動脈塞栓療法(TACE)は,肝細胞癌の代表的な治療法のひとつであり,有用性については認知されている.一方,手技上TACE不可能な症例には肝動脈化学療法(Lip-TAI)が汎用されるが,局所コントロールが不良との指摘もある.われわれは,新たな肝動脈カテーテル療法(Lip+DSM-TAI)を考案したので,その有用性について紹介する.
Transcatheter arterial chemoembolization (TACE) has become one of the most popular for hepatocellular carcinoma (HCC) patients. TACE has been reported to be a useful treatment. On the other hand, transcatheter arterial infusion chemotherapy using an emulsion of iodized oil (lipiodol) and an anticancer agent (Lip-TAI) (without gelatin sponge particle) has usually been performed for HCC patients in whom the catheter could not be inserted in the targeted segment or a feeding artery was not detected in the tumor. However, it has been reported that the effect of Lip-TAI was lower than that of TACE in the local tumor control. We designed a novel transcatheter arterial infusion chemotherapy using lipiodol and degradable starch microspheres[Lip+DSM-TAI]for HCC patients. We induct the efficacy of this novel therapy.
Subjects
医学 ( Other)
Languages jpn
Resource Type journal article
Publishers 山口大学医学会
Date Issued 2011-10-31
File Version Version of Record
Access Rights open access
Relations
[ISSN]0513-1731
[NCID]AN00243156
Schools 医学部